CSIMarket
 
Bioatla Inc   (NASDAQ: BCAB)
 

Bioatla Inc's Suppliers Performance

BCAB's Supply Chain




 
BCAB Costs vs Sales of Suppliers Growth

More on BCAB Suppliers






Bioatla Inc's Comment on Supply Chain


The company sources raw materials for its product candidates, occasionally from single-source suppliers. It utilizes internal expertise and third-party manufacturers for manufacturing, filling, labeling, packaging, storage, and distribution of investigational drug products. The company holds agreements with manufacturers that include confidentiality and intellectual property provisions. It employs personnel experienced in manufacturing and quality management to oversee third-party manufacturing activities. The company has a clinical trial collaboration and supply agreement with Bristol-Myers Squibb Company (BMS), under which BMS provides Opdivo® clinical drug supply at no cost. Additionally, the company had a collaboration with BeOne Medicines, Ltd. (formerly BeiGene, Ltd.) for the development, manufacturing, and commercialization of an investigational antibody; this collaboration was terminated in 2021, with certain provisions remaining in effect.

Bioatla Inc's Comment on Supply Chain


The company sources raw materials for its product candidates, occasionally from single-source suppliers. It utilizes internal expertise and third-party manufacturers for manufacturing, filling, labeling, packaging, storage, and distribution of investigational drug products. The company holds agreements with manufacturers that include confidentiality and intellectual property provisions. It employs personnel experienced in manufacturing and quality management to oversee third-party manufacturing activities. The company has a clinical trial collaboration and supply agreement with Bristol-Myers Squibb Company (BMS), under which BMS provides Opdivo® clinical drug supply at no cost. Additionally, the company had a collaboration with BeOne Medicines, Ltd. (formerly BeiGene, Ltd.) for the development, manufacturing, and commercialization of an investigational antibody; this collaboration was terminated in 2021, with certain provisions remaining in effect.







BCAB's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Bioatla Inc 2.97 0.00 -31.45 41
SUBTOTAL 0.00 0.00 0.00 -


Sources: Bioatla Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Bioatla Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.